Match the Drug in Column 1 with Its Drug Category

question 59

Short Answer

Match the drug in Column 1 with its drug category in Column 2.
A)topical combination anesthetic drug
B)topical corticosteroid drug
C)topical drug for warts
D)drug used to treat alopecia
E)drug used for herpes simplex type 1 and 2
F)drug used to treat acne rosacea
G)topical antifungal drug
H)oral immunomodulator drug for psoriasis
I)vulgaris and psoriasis
J)combination antibiotic/corticosteroid drug
1)EMLA (lidocaine,prilocaine)
2)etanercept (Enbrel)
3)Cortisporin
4)hydrocortisone (Dermolate,Westcort)
5)ketoconazole (Nizoral A-D,Xologel)
6)brimonidine (Mirvaso)
7)minoxidil (Rogaine)
8)salicylic acid (Compound W,Dr.Scholl's)
9)tazarotene (Tazorac)
"10)valacyclovir (Valtrex)

• A)topical combination anesthetic drug
• B)topical corticosteroid drug
• C)topical drug for warts
• D)drug used to treat alopecia
• E)drug used for herpes simplex type 1 and 2
• F)drug used to treat acne rosacea
• G)topical antifungal drug
• H)oral immunomodulator drug for psoriasis
• I)vulgaris and psoriasis
• J)combination antibiotic/corticosteroid drug
• 1)EMLA (lidocaine,prilocaine)
• 2)etanercept (Enbrel)
• 3)Cortisporin
• 4)hydrocortisone (Dermolate,Westcort)
• 5)ketoconazole (Nizoral A-D,Xologel)
• 6)brimonidine (Mirvaso)
• 7)minoxidil (Rogaine)
• 8)salicylic acid (Compound W,Dr.Scholl's)
• 9)tazarotene (Tazorac)
• "10)valacyclovir (Valtrex)

---

Definitions:

Unadjusted Trial Balance

A list of all the general ledger accounts and their balances at a certain point in time before any adjustments are made.

Adjusted Trial Balance

A list of all account balances in the general ledger after adjustments, used to prepare financial statements and ensure the accuracy of the accounts.

Income Statement

The income statement, also known as a profit and loss statement, provides a summary of a company's revenues, costs, and expenses incurred during a specific period, illustrating the company's financial performance.

Statement of Retained Earnings

A financial document that summarizes the changes in retained earnings for a specific period, factoring in net income and dividends paid.